Doximity, Inc. (NASDAQ:DOCS) Director Regina M. Benjamin Sells 10,000 Shares

Doximity, Inc. (NASDAQ:DOCS) Director Regina M. Benjamin sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the transaction, the director now owns 16,618 shares of the company’s stock, valued at approximately $997,080. This trade represents a 37.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Doximity Stock Up 1.3%

NASDAQ:DOCS opened at $61.19 on Friday. Doximity, Inc. has a twelve month low of $25.00 and a twelve month high of $85.21. The company has a fifty day moving average of $56.21 and a 200-day moving average of $58.74. The firm has a market capitalization of $11.49 billion, a P/E ratio of 61.19, a P/E/G ratio of 4.10 and a beta of 1.33.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings results on Thursday, May 15th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period in the previous year, the business earned $0.25 earnings per share. Doximity’s quarterly revenue was up 17.1% on a year-over-year basis. On average, analysts anticipate that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Institutional Trading of Doximity

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Global Retirement Partners LLC grew its stake in Doximity by 468.1% in the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock valued at $29,000 after acquiring an additional 440 shares during the period. VSM Wealth Advisory LLC bought a new position in shares of Doximity in the 1st quarter worth $29,000. Allworth Financial LP grew its position in Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company’s stock valued at $32,000 after purchasing an additional 287 shares during the period. National Bank of Canada FI bought a new stake in Doximity during the 1st quarter valued at $33,000. Finally, Spire Wealth Management raised its holdings in Doximity by 73.2% during the first quarter. Spire Wealth Management now owns 615 shares of the company’s stock worth $36,000 after buying an additional 260 shares during the last quarter. 87.19% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

DOCS has been the topic of several analyst reports. Bank of America boosted their price objective on shares of Doximity from $55.00 to $62.00 and gave the stock a “neutral” rating in a research note on Wednesday. Mizuho cut their target price on Doximity from $65.00 to $60.00 and set a “neutral” rating on the stock in a report on Friday, May 16th. Morgan Stanley decreased their price target on Doximity from $71.00 to $60.00 and set an “equal weight” rating for the company in a research note on Thursday, April 24th. The Goldman Sachs Group set a $50.00 price objective on Doximity and gave the stock a “neutral” rating in a research report on Wednesday, May 21st. Finally, Canaccord Genuity Group reduced their target price on Doximity from $71.00 to $50.00 and set a “hold” rating on the stock in a report on Friday, May 16th. Eleven research analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $63.11.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.